We therefore investigated the levels of FACT proteins and the reported targets of curaxin in CML before assessing the ability of the curaxin CBL0137 to extinguish CML primitive cells. Here, SSRP1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.